Current Vet

In this episode of Current Vet, Dr. Lottie talks about canine atopic dermatitis, how genetics, skin barrier dysfunction and the immune system drive the itch-scratch cycle, the key clinical signs to recognise, why it’s a diagnosis of exclusion, and the treatment options for long-term control.

CLICK HERE TO VISIT OUR BRAND NEW WEBSITE!

Find us on TikTok & Instagram: @veterinaryvista

Timeline:
00:00 Intro

00:37 Case

02:22 Aetiology & Pathogenesis

06:09 Clinical Signs

08:59 Diagnosis

15:05 Treatment

21:13 Allergen-Specific Immunotherapy

23:45 Key Points

25:18 Outro

References & Further Reading
  • Bizikova, P. et al. (2015) ‘Review: Clinical and histological manifestations of canine atopic dermatitis’, Veterinary Dermatology, 26(2), pp. 79-e24. Available at: https://doi.org/10.1111/vde.12196.
  • Santoro, D. et al. (2015) ‘Review: Pathogenesis of canine atopic dermatitis: skin barrier and host–micro-organism interaction’, Veterinary Dermatology, 26(2), pp. 84-e25. Available at: https://doi.org/10.1111/vde.12197.
  • Eisenschenk, M.C. et al. (2024) ‘Introduction to the ICADA 2023 canine atopic dermatitis pathogenesis review articles and updated definition’, Veterinary Dermatology, 35(1), pp. 3–4. Available at: https://doi.org/10.1111/vde.13183.
  • Favrot, C. et al. (2010) ‘A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis’, Veterinary Dermatology, 21(1), pp. 23–31. Available at: https://doi.org/10.1111/j.1365-3164.2009.00758.x.
  • Hensel, P. et al. (2015) ‘Canine atopic dermatitis: detailed guidelines for diagnosis and allergen identification’, BMC Veterinary Research, 11(1), p. 196. Available at: https://doi.org/10.1186/s12917-015-0515-5.
  • Santoro, D. (2019) ‘Therapies in Canine Atopic Dermatitis: An Update’, Veterinary Clinics: Small Animal Practice, 49(1), pp. 9–26. Available at: https://doi.org/10.1016/j.cvsm.2018.08.002.
  • Schnabl, B. et al. (2006) ‘Results of allergen-specific immunotherapy in 117 dogs with atopic dermatitis’, Veterinary Record, 158(3), pp. 81–85. Available at: https://doi.org/10.1136/vr.158.3.81.
  • Saridomichelakis, M.N. and Olivry, T. (2016) ‘An update on the treatment of canine atopic dermatitis’, The Veterinary Journal, 207, pp. 29–37. Available at: https://doi.org/10.1016/j.tvjl.2015.09.016.

Current Vet is an educational podcast intended for veterinary students, veterinary professionals, and individuals with an interest in veterinary medicine.

All content provided in this podcast and its associated materials is for educational and informational purposes only. It is not intended as, and must not be considered a substitute for, professional veterinary advice, diagnosis, or treatment.

Any clinical cases discussed in this podcast are fictional, and are designed to reflect typical or likely clinical scenarios for educational purposes. They do not represent specific real-life cases, clients, or animals.

While every effort is made to ensure accuracy and alignment with current evidence at the time of publication, veterinary medicine is a rapidly evolving field, and recommendations may change over time.

Creators and Guests

Host
Dr. Lottie Wilkinson
Creator and host of the Current Vet podcast

What is Current Vet?

The podcast that makes veterinary medicine simple.

In each episode, Dr. Lottie breaks down clinical conditions, cases, and concepts across species, focusing on pathophysiology, decision-making, diagnostics, and what actually matters in practice. It’s the kind of context that makes your knowledge finally click.

Every month, we’ll also have honest conversations with guests about the incredible variety of veterinary medicine, what you can do with a vet degree and how to think bigger about your career.

Whether you’re cramming for exams or looking for a soundtrack for your dog walk, Current Vet will make vet med simple

Canine Atopic Dermatitis
===

[00:00:00] Hello, hello, and welcome back to Current Vet. If you're new here, this is the podcast that makes veterinary medicine simple. I'm Dr. Lottie, and today we're talking about one of the most common conditions you'll see in small animal practice, and that is canine atopic dermatitis. Whether you're a student preparing for exams, new graduate seeing your first itchy dog consults, or you just want a refresher, this is a condition that's well worth understanding. It's incredibly common, but it's also one of the diseases that is quite misunderstood. So let's start with a case.

You're working in first-opinion practice when Honey, a three-year-old female neutered golden retriever, comes in for another skin consult. Her owner says she's been itchy on and off for about a year, but over the past few months, things have become much worse. Honey is constantly licking her paws, rubbing her face along the carpet, and scratching at her ears. She's also had two ear infections in the [00:01:00] last six months, both of which improved with treatment, but have come back a couple of weeks later. The owner's tried changing her food. She's bathing her more often and using over-the-counter shampoos, but just nothing seems to be working. On exam, Honey is bright and otherwise healthy. You notice she has brown saliva staining between the toes from her chronically licking and chewing them, some mild erythema on both front paws, erythema around the lips and muzzles, as well as both pinnae, thickened hyperpigmented skin in the axilla, no obvious fleas, and no evidence of systemic illness.

So what's on your differential list? We could be dealing with, obviously, canine atopic dermatitis, potentially a cutaneous adverse food reaction, often referred to as just a food allergy, could be flea allergy dermatitis, maybe something like sarcoptic mange or mite infestations, bacterial or yeast [00:02:00] infections, and less commonly, it could be something like contact dermatitis. But at this stage, you can't confidently diagnose atopic dermatitis because it is a diagnosis of exclusion, meaning it's diagnosed by combining the history, the clinical signs, and then excluding all other causes of pruritus

So what is canine atopic dermatitis? CAD is a chronic inflammatory and pruritic skin disease. It develops because of three major factors. So the first is a genetic predisposition. Some breeds are much more commonly affected than others, including golden retrievers, Labrador retrievers, West Highland white terriers, French bulldogs, boxer dogs, German shepherd dogs. There are several breeds, but not every dog from these breeds is obviously gonna develop CAD, they just have a higher risk of developing it than other breeds. The second factor is going to be a skin [00:03:00] barrier dysfunction. So normally, the outer layer of the skin is acting like a wall. It's creating a strong barrier that keeps moisture in the body, and allergens, bacteria, and irritants out of the body. So in dogs with atopic dermatitis, that barrier just isn't as effective, and small defects in this protective layer are gonna allow environmental allergens to penetrate the deeper layers of skin much more easily. The third factor is going to be an abnormal immune response. So once allergens cross the damaged skin barrier, the immune system overreacts. So instead of tolerating these harmless substances from the environment, it recognizes them as threats and mounts an exaggerated inflammatory response. The important thing here is that the allergens themselves aren't usually harmful. They're often things that healthy dogs are exposed to most days without experiencing any [00:04:00] problems.

So when an at-risk dog is exposed to environmental allergens, these might be house dust mites, pollen, mold spores, could be storage mites. These allergens settle on the skin, but because that skin barrier is weak, they can penetrate through the outer layers much more easily than they would in a healthy dog. Once they've crossed the skin barrier, they are then recognized by immune cells called antigen-presenting cells. Their job is to capture allergens and present them to another group of immune cells called T lymphocytes. In dogs with atopic dermatitis, that response is exaggerated. So these activated T cells begin releasing signaling molecules called cytokines. And cytokines are essentially chemical messengers that allow immune cells to communicate with each other. Several cytokines are gonna contribute to inflammation in canine atopic dermatitis, but interleukin-31 is [00:05:00] particularly important. So IL-31 binds directly to receptors on sensory nerves within the skin, and rather than just causing inflammation, it actually stimulates the nerves responsible for transmitting the sensation of itch to the brain. So that dog responds to that itch by scratching, by licking, chewing, rubbing affected areas, and that repeated self-trauma damages the skin barrier even further, meaning more allergens can penetrate the skin. More allergens trigger more inflammation. More inflammation is more itch, and that is creating that itch-scratch cycle. The disease essentially becomes self-perpetuating. And another important consequence of barrier damage is that bacteria and yeast that are normal parts of the skin microflora can become overgrown and can develop into opportunistic infections. These secondary infections don't cause canine atopic dermatitis, but they [00:06:00] further contribute to inflammation and then more pruritus.

Okay, so now we understand what is happening underneath the skin. Let's look at how these dogs actually present in practice. So the most important clinical sign to remember is pruritus. Owners are often gonna tell you their dog is constantly licking or chewing their paws or scratching their ears, rubbing their face, but most dogs are otherwise quite bright, healthy, and systemically well. There is a pretty characteristic lesion distribution. commonly affected sites are gonna include the paws and the interdigital skin, the pinna and the ear flaps, the face and muzzle, the periocular region, the axilla, and then the ventral abdomen. Another useful way to think about the clinical signs is to separate primary lesions, which are caused directly by the inflammation, from secondary lesions, which [00:07:00] develop because the dog has been scratching for weeks or months. So early on in the disease, we might see only these primary lesions like mild erythema, some small papules, or some excoriations from scratching as well. As the disease becomes chronic, repeated inflammation and then self-trauma are also gonna lead to alopecia, hyperpigmentation, lichenification, which is where the skin becomes really thickened, saliva staining, particularly around the paws. We can see crusting, And we can see scaling. So these chronic changes are gonna tell you that the disease has been present for quite some time. If we then also have secondary infections, we might also see papules, pustules, crusting, and epidermal collarettes as well. A Malassezia dermatitis caused by overgrowth of the yeast Malassezia pachydermatitis. These dogs often have greasy [00:08:00] skin, erythema, a brown discoloration, and then quite a musty or yeasty odor and marked pruritus as well

We also need to mention recurrent ear disease because it is incredibly common in dogs with CAD. Some dogs might even present with recurrent otitis externa before obvious skin disease develops. So if you have a young dog with repeated ear infections, especially if they're bilateral, CAD should be high on your differential list. So if we go back to Honey, she has that paw-licking, she is rubbing her face, she has recurrent bilateral otitis externa episodes. She also has erythema around the paws, the muzzle, and lichenification in the axilla. So all together, that's gonna be very typical of canine atopic dermatitis.

So at this point, canine atopic dermatitis is looking very likely, but we still haven't diagnosed it. [00:09:00] And as we said before, CAD is a diagnosis of exclusion, which means we have to go through and reasonably rule out other causes of this presentation before we can officially diagnose CAD. So let's go through what a good diagnostic process might look like. First of all, the history is gonna give some good clues. We're gonna be interested in questions like when did the itching first start? Is it seasonal or all year round? Which body areas seem to be affected? Have we been using consistent flea control? What treatments have helped before? Has the dog's diet changed? And do we have any signs of recurrent ear or other skin infections?

Honey's owner says she first became itchy around two years old, and she initially flared during spring and summer but over the past year she's become itchy throughout the year.

Step two is gonna be a good physical exam. So we're gonna be assessing the lesion distribution, the severity, evidence of self-trauma, whether there's any [00:10:00] fleas or flea dirt in the fur, signs of pyoderma and secondary infection, and then we also want to check the ear canals.

step three is going to be to rule out ectoparasites. This can include skin scrapings, like deep and superficial skin scrapes, coat brushing, acetate tape preparations, and then flea combing as well. Even if these are negative, many clinicians are still going to recommend a trial of effective ectoparasite treatments, particularly if there's suspicion of flea allergy or sarcoptic mange. Because remember that negative skin scrapings or flea combs are not definitively ruling out that there are infestations

Step four is gonna be cytology. So cytology is a quick, inexpensive test and can be performed in clinic, so it is very useful to do. We can collect samples using an acetate tape collection, direct impression smears, or using cotton swabs from [00:11:00] ears or directly of lesions. And we're gonna be looking for evidence of bacteria, either cocci or rods, neutrophils, and Malassezia yeast as well.

If there are signs of secondary infection, we need to make sure that is included in the treatment plan. Otherwise, we're gonna struggle to actually assess how much of the itch is coming from the underlying allergy, if there is one, versus an infection.

Step five is going to be an elimination diet trial. So because food allergies present very similarly to atopic dermatitis, they have to be excluded, and this is done using an elimination diet trial, usually for around eight to 10 weeks. And the dog is fed either a hydrolyzed protein diet, where the proteins are broken down into fragments so they're too small to trigger most immune responses, or we feed a novel protein diet, so that is gonna contain proteins that the dog has never eaten before.[00:12:00]

Really importantly, the dog must eat nothing else during the trial. We're not allowed treats, no flavored medications, no table scraps, no dental chews. If the pruritus improves and then returns when the original diet is reintroduced, that is strongly suggestive of a cutaneous adverse food reaction. If there is no meaningful improvement, food allergy is much less likely.

So Honey completes an eight-week diet trial on a hydrolyzed diet with really good owner compliance. Her pruritus improves a tiny bit, but she does remain persistently itchy, and that makes the food allergy unlikely, and it's gonna strengthen our suspicion of canine atopic dermatitis.

Step six is Favrot's criteria. So once other major causes and other major differentials have been excluded, we can use Favrot's criteria. These are a [00:13:00] group of clinical features in a case that increase the likelihood of the diagnosis being CAD. So the criteria here are gonna be onset before three years old, the dog lives primarily indoors the pruritus is glucocorticoid responsive. Pruritus affects the front feet. The ear pinnae are affected. The ear margins are not affected. The dorsolumbar region is not affected, and then chronic or recurrent yeast infections are seen. These are not gonna be diagnostic. They're just increasing the confidence that this case is consistent with canine atopic dermatitis. So if the case matches five out of eight of these criteria, that is strongly supportive of canine atopic dermatitis.

So where does allergy testing fit in? A lot of people are gonna assume that you [00:14:00] perform an allergy test to diagnose but you actually don't. Neither intradermal allergy testing nor serum allergen specific IgE testing can diagnose atopic dermatitis. These tests simply identify which allergens an already diagnosed dog is reacting to, either through injecting the allergens into the intradermal layer and assessing a response, or through directly identifying allergen-specific antibodies within a blood sample.

So their main purpose is to formulate an allergen-specific immunotherapy, which we're going to discuss in the treatment section. So for Honey, we've taken a thorough history, we've performed a clinical exam, we've ruled out ectoparasites, we've identified secondary infections We've completed an elimination diet trial, and we found that her clinical signs fit atopic dermatitis. So at this point, we're fairly confidently able to diagnose canine atopic dermatitis.

So now that we've diagnosed [00:15:00] Honey, it's time to think about treatment. There isn't gonna be a single best treatment, so the goals are to reduce itch, restore the skin barrier, control inflammation, and prevent flare-ups, all while maintaining a good quality of life. first up, we've got the treat secondary infections. secondary infections don't cause CAD, but they make it significantly worse. So if Honey has a superficial bacterial pyoderma or a Malassezia dermatitis, we need to treat that appropriately before we can actually be able to judge how well her allergy treatment is working. so treatments are gonna involve topical antiseptics or chlorhexidine and then topical antifungals or antibiotics depending on what is causing the infection.

Next up, we're gonna repair and support the skin barrier. So the skin barrier is abnormal in dogs, typically abnormal in dogs with CAD. So helping to restore it can [00:16:00] reduce the allergen penetration into the skin and improve long-term control of the condition. supportive measures can include regular bathing with a gentle moisturising shampoo, something like an oat or chamomile shampoo, moisturisers and other products with ceramides or barrier lipids in them, and then making sure that we're feeding or supplementing some essential fatty acids which can help to reduce inflammation. Using the right products here can help improve skin hydration, we can remove allergens from the coat, and we can help to reduce microbial overgrowth as well.

So the third step is going to be controlling itch and inflammation, which is really the mainstay of treatment. So glucocorticoids, the first choice of which is prednisolone, are most often used. these work by altering gene transcription, which then leads to a suppressed immune response and reduced inflammatory cytokine production. So [00:17:00] obviously, the main advantages here are gonna be It's got a rapid onset, prednisolone is fairly inexpensive, and it's really good at controlling flares. But the disadvantages are gonna come with if we're using this in the long term, and potential adverse effects are gonna include polyuria, polydipsia, polyphagia, weight gain, increased risk of infections because we're suppressing that immune response, muscle wasting, And then with excessive or prolonged use, we can induce iatrogenic hyperadrenocorticism. So because of this, they're generally preferred for short-term flare control or if other options aren't as suitable for long-term treatment Oclacitinib is one of the most commonly used medications in GP, and that inhibits Janus kinase or JAK enzymes.

So without getting too deep into this, JAK enzymes help to transmit signals from several inflammatory cytokines, including IL-31. And by [00:18:00] blocking these signals, Oclacitinib reduces itch. So pros of this are it has a quick onset, it has really good control of the itch response, it can be orally administrated, and it's suitable for most long-term cases. But the limitations are that it doesn't work for every dog. It requires daily tablets, so if you struggle to tablet your pet, that's gonna be really difficult. it generally shouldn't be used in dogs under 12 months old because of concerns about immunosuppression while they are growing.

Lokivetmab is another option. So unlike Oclacitinib, it is a monoclonal antibody. so instead of blocking cell signaling, it directly binds to IL-31 itself. So you can basically think of this as removing the itch messenger before it reaches the receptor. And because it's really targeted, it has very little side effects on the rest of the immune system.

So advantages here [00:19:00] are that it is a monthly injection, so we don't need to faff about with daily tablets. It quite quickly relieves itching. It has a pretty quick onset of action and helps to relieve itches quickly. It's very safe compared to other options because it has that very targeted approach and few side effects.

And it's, as we said, very useful when owners struggle to tablet their pets. Some limitations are gonna be that some dogs respond better than others, and also that it requires repeat injections.

Another option here is going to be cyclosporine. So cyclosporine has been used quite successfully for a lot of years in canine atopic dermatitis. It suppresses activation of T lymphocytes, which then reduces the abnormal immune response that's driving the disease. But it takes around four to eight weeks to start seeing clinical improvements.

So its advantages are that it's a good long-term option and it avoids a [00:20:00] lot of the side effects associated with those chronic glucocorticoid administration. But the disadvantages are a slow onset. It's quite a lot more expensive than some alternatives, and we can also see GI side effects like vomiting and diarrhea, especially at the start of treatments.

Because it takes quite a long time to work, clinicians can actually use a short course of another medication during that induction period whilst we're waiting for the cyclosporine to start kicking in. So there isn't gonna be one correct answer out of all these drug options. So for an acute flare, we might be looking at glucocorticoids or oclacitinib because they act pretty quickly.

But for long-term management, many dogs do well with oclacitinib, lokivetmab, or cyclosporine. But the choice depends on, things like the severity of disease, if they have any concurrent illnesses, the owner preference, ease of administration, and cost as well, and then any previous treatment [00:21:00] responses, whether they have been effective or not.

Okay, let's quickly come back to allergen-specific immunotherapy and allergy testing. So remember that we don't perform allergy testing to diagnose CAD. We perform it after diagnosis if we're considering allergen-specific immunotherapy. So how it works is that once allergy testing identifies the environmental allergens that the individual dog is reacting to, a mix of those allergens can be produced.

The dog then receives gradually increasing doses of these allergens over time, and the aim here is to teach the immune system to become more tolerant of those allergens, which helps to reduce that exaggerated response when the dog encounters them naturally. It's the closest thing we have to a treatment that addresses the underlying disease process rather than simply just controlling the clinical signs. The main advantages here are going to be it can reduce long-term medication requirements [00:22:00] because if we're not reacting as severely to those allergens, we don't need to control as extreme responses.

It can provide lasting improvements and it has a very good safety index. The disadvantages here are going to be that it doesn't work for every dog. Improvements can take many months or up to even a year perhaps, and it requires really good owner compliance.

Finally, for treatment, we need to consider environmental management. So completely avoiding environmental allergens is generally impossible. After all, we can't remove every pollen grain or dust mite from a dog's environment, but we can try and reduce allergen exposure. So some examples here are gonna be to wash bedding regularly, rinse paws

after walks during high pollen seasons, regular grooming, keeping up with good flea prevention, and managing any concurrent infections really quickly. These changes [00:23:00] obviously aren't gonna cure CAD, but they can reduce the frequency or the severity of flare-ups.

CAD is generally considered a lifelong condition. So regular rechecks are gonna be important to assess itch levels, look for secondary infections, monitor response to treatment, making sure there are no clinical adverse effects from the medications, and then adjusting that management plan as needed. but the great thing here is that with appropriate long-term management, most dogs can have a really excellent quality of life.

Okay, before we finish, here are the key points to know. Canine atopic dermatitis is a chronic genetically predisposed inflammatory skin condition characterized by pruritus. The disease develops because skin barrier dysfunction, immune dysregulation, and environmental allergens interact to create a self-perpetuating itch scratch and inflammation cycle.

[00:24:00] Pruritus often develops before obvious skin lesions, and then the paws, the face, the ears, and the ventrum and axilla are commonly affected. CAD is a diagnosis of exclusion, so we need to rule out things like ectoparasites, flea allergies, food allergies, and then secondary infections before making a diagnosis.

Allergy testing does not diagnose canine atopic dermatitis. It is used only to formulate allergen-specific immunotherapy once a diagnosis has been made. Our management approach is gonna be multimodal, including treatment of any secondary infections. We're gonna be supporting that skin barrier, giving antipruritic medications, anti-inflammatories, and then in selected cases, we may use allergen-specific immunotherapy as well.

Most importantly here, remember that the goal isn't to cure atopic dermatitis, it's to achieve long-term control [00:25:00] while maintaining a good quality of life. And that is canine atopic dermatitis.

Thank you so much for listening to Current Vet. If you found this episode helpful, follow or subscribe wherever you listen to podcasts and share it with someone who might find it useful as well. If there are any topics you'd like us to cover next, let us know in the comments, or come and find us on TikTok and Instagram @veterinaryvista. We'll see you next time.